| Revitalization of Damaged Skin Due to Chronic Skin Diseases (NCT03485560) | Ace Cells Lab Limited | 2018-05-01 |
| A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD (NCT03539601) | Pfizer | 2018-04-27 |
| A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis (NCT03568071) | Lakefront Biotherapeutics NV | 2018-04-26 |
| Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD) (NCT03269773) | Kang Stem Biotech Co., Ltd. | 2018-04-25 |
| A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis (NCT03334435) | Eli Lilly and Company | 2018-03-28 |
| The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy (NCT04018131) | Fakultas Kedokteran Universitas Indonesia | 2018-03-26 |
| Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND (NCT03587805) | LEO Pharma | 2018-03-18 |
| Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) (NCT03540160) | Vyne Therapeutics Inc. | 2018-03-15 |
| Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO) (NCT06551363) | University Hospital, Brest | 2018-03-01 |
| Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 (NCT03363854) | LEO Pharma | 2018-02-22 |
| A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis (NCT03435081) | Eli Lilly and Company | 2018-02-20 |
| Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (NCT03415282) | Dermavant Sciences GmbH | 2018-02-05 |
| Efficacy of Topical Coal Tar in Children With Atopic Dermatitis (NCT03461302) | Radboud University Medical Center | 2018-02-01 |
| A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (NCT03443024) | Eli Lilly and Company | 2018-01-30 |
| A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis (NCT03492398) | Shaperon | 2018-01-29 |
| Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (NCT03394677) | Dermavant Sciences GmbH | 2018-01-25 |
| A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis (NCT03356977) | Pfizer | 2018-01-16 |
| Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin (NCT03484897) | Derming SRL | 2018-01-12 |
| Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis (NCT03381625) | BioMimetix JV, LLC | 2018-01-02 |
| Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children (NCT06063044) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-01-01 |
| BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis (NCT03549416) | UMC Utrecht | 2018-01-01 |
| Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life (NCT04900948) | National Medical Research Center for Children's Health, Russian Federation | 2017-12-10 |
| Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis (NCT03351777) | Realm Therapeutics, Inc. | 2017-12-04 |
| Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis (NCT03334422) | Eli Lilly and Company | 2017-11-27 |
| A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis (NCT03334396) | Eli Lilly and Company | 2017-11-23 |
| A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis (NCT03431610) | Novan, Inc. | 2017-11-13 |
| Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients (NCT03327116) | University of Sao Paulo General Hospital | 2017-11-01 |
| Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis (NCT04613037) | Tel-Aviv Sourasky Medical Center | 2017-11-01 |
| Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis (NCT03315611) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2017-10-02 |
| Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy (NCT03089476) | National Jewish Health | 2017-09-30 |
| A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis (NCT03304470) | UNION therapeutics | 2017-09-25 |
| Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB Treatment (NCT03402412) | Oslo University Hospital | 2017-09-19 |
| Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis (NCT03252340) | EHL Bio Co., Ltd. | 2017-09-19 |
| A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis (NCT03260595) | Pfizer | 2017-09-13 |
| Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions (NCT03198390) | University of Arizona | 2017-08-04 |
| Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis (NCT03083730) | Rockefeller University | 2017-07-19 |
| An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis (NCT03758716) | Fountain Biopharma Inc. | 2017-07-03 |
| Dose-ranging Study of Nemolizumab in Atopic Dermatitis (NCT03100344) | Galderma R&D | 2017-06-14 |
| Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) (NCT03160885) | LEO Pharma | 2017-06-12 |
| Evaluating the Effects of Cleansers on the Skin (NCT03188653) | University of Arizona | 2017-05-31 |
| Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) (NCT03131648) | LEO Pharma | 2017-05-30 |
| Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic Dermatitis (NCT03375970) | China Medical University Hospital | 2017-05-02 |
| A Study in Subjects With Moderate Atopic Dermatitis (NCT03175354) | Ralexar Therapeutics, Inc. | 2017-04-26 |
| A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis (NCT02871479) | Santalis Pharmaceuticals, Inc. | 2017-04-21 |
| Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis (NCT03018275) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-04-20 |
| Prospective Longitudinal Observational Research in Atopic Dermatitis (NCT04240522) | University of Zurich | 2017-04-04 |
| Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis (NCT03051958) | Karolinska Institutet | 2017-03-29 |
| A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis (NCT03089229) | Haus Bioceuticals | 2017-03-26 |
| Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis (NCT03091426) | Maruho Co., Ltd. | 2017-03-08 |
| Bathing Babies and Allergy (NCT03050658) | University of Virginia | 2017-02-07 |
| Evaluating Treatment Resistant Dermatitis TaroIIR (NCT03050294) | Wake Forest University Health Sciences | 2017-02-01 |
| EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic Eczema (NCT03376243) | University Hospital Schleswig-Holstein | 2017-02-01 |
| Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis (NCT02908698) | McMaster University | 2017-01-24 |
| Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis (NCT03157284) | Heinz Italia SpA | 2017-01-23 |
| Molecular Signatures in Inflammatory Skin Disease (NCT03358693) | Prof. Dr. Stephan Weidinger | 2017-01-20 |
| A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis (NCT03011892) | Incyte Corporation | 2017-01-09 |
| Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients (NCT02864498) | DS Biopharma | 2017-01-01 |
| Trial on Vascular Inflammation in Atopic Dermatitis (NCT02926807) | Innovaderm Research Inc. | 2017-01-01 |
| Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) (NCT03253666) | Harvard School of Public Health (HSPH) | 2017-01-01 |
| Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis (NCT03018691) | Otsuka Pharmaceutical Co., Ltd. | 2017-01-01 |
| Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic Dermatitis (NCT02716181) | Avanta Trading Ltd. | 2016-12-29 |
| Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD) (NCT02925793) | DS Biopharma | 2016-12-01 |
| Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis (NCT03250624) | Galderma R&D | 2016-11-01 |
| CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis (NCT02965118) | Amorepacific Corporation | 2016-11-01 |
| Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis (NCT02950922) | Dermavant Sciences GmbH | 2016-11-01 |
| A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis (NCT02925117) | AbbVie | 2016-10-25 |
| DMT210 Topical Gel in the Treatment of Atopic Dermatitis (NCT02949960) | Dermata Therapeutics | 2016-10-01 |
| Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis (NCT02945657) | Medimetriks Pharmaceuticals, Inc | 2016-10-01 |
| Study of OPA-15406 Ointment in Patients With Atopic Dermatitis (NCT02914548) | Otsuka Pharmaceutical Co., Ltd. | 2016-09-01 |
| Antipruritic Effect of Acupuncture in Patients With Atopic Dermatitis (NCT02844452) | Kyunghee University | 2016-09-01 |
| Topical Solution for the Treatment of Atopic Dermatitis (NCT02865356) | Spherium Biomed | 2016-09-01 |
| Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments (NCT03051347) | Northwestern University | 2016-09-01 |
| An Open Label, Safety Study to Assess the Potential for Adrenal Suppression. (NCT02932891) | Sun Pharmaceutical Industries, Inc. | 2016-08-01 |
| Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis (NCT02896101) | Glenmark Pharmaceuticals Ltd. India | 2016-08-01 |
| Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (NCT02888704) | EHL Bio Co., Ltd. | 2016-07-01 |
| Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj. (NCT03458624) | Kang Stem Biotech Co., Ltd. | 2016-07-01 |
| A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis (NCT02795832) | Ziarco Pharma Ltd | 2016-06-01 |
| Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis (NCT03297502) | Par Pharmaceutical, Inc. | 2016-06-01 |
| The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis (NCT02840955) | Erasmus Medical Center | 2016-06-01 |
| Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD) (NCT02889081) | Children's Hospital of Fudan University | 2016-06-01 |
| Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival (NCT01960764) | University of California, San Diego | 2016-06-01 |
| Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores (NCT02779426) | Columbia University | 2016-05-01 |
| Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy (NCT02763722) | Medical University of Warsaw | 2016-05-01 |
| Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis (NCT02743871) | Pfizer | 2016-04-27 |
| Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis (NCT02780167) | Pfizer | 2016-04-01 |
| A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests (NCT03406117) | Haus Bioceuticals | 2016-04-01 |
| Identification of Epidermal Signatures in Patients With Atopic Dermatitis (NCT02680405) | National Jewish Health | 2016-04-01 |
| To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis (NCT02683928) | Ichnos Sciences SA | 2016-03-01 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis (NCT02748993) | Amorepacific Corporation | 2016-03-01 |
| Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis (NCT03107611) | Mylan Inc. | 2016-02-29 |
| Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema (NCT02691507) | Johnson & Johnson Consumer Inc. (J&JCI) | 2016-02-01 |
| A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis (NCT02576938) | Eli Lilly and Company | 2016-02-01 |
| A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable (NCT02755649) | Regeneron Pharmaceuticals | 2016-01-31 |
| Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis (NCT02651714) | Vanda Pharmaceuticals | 2016-01-19 |
| Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD) (NCT02647086) | Regeneron Pharmaceuticals | 2015-12-01 |
| Secukinumab for Treatment of Atopic Dermatitis (NCT02594098) | Icahn School of Medicine at Mount Sinai | 2015-11-01 |
| PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo (NCT02537509) | Rennes University Hospital | 2015-10-27 |
| Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD) (NCT02612454) | Regeneron Pharmaceuticals | 2015-10-15 |
| Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis (NCT03676933) | DS Biopharma | 2015-10-01 |
| Indigo Naturalis in Treating Atopic Dermatitis Topically (NCT02669888) | Chang Gung Memorial Hospital | 2015-10-01 |